All In MedTech

Device Trial Radar · NCT07444372

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation: A Multicenter, Open-label, Randomized Clinical Trial

Last checked: Nov 19, 2026Latest source record: Oct 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 658 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

658

Planned (sponsor's estimate)

Start

May 12, 2026

Primary completion

Jan 31, 2029

Study completion Jan 31, 2029

Sponsor

Lead sponsor
Beijing Anzhen HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Mar 2, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Atrial fibrillation (AF) is one of the most common clinical arrhythmias. Catheter ablation is an effective therapeutic strategy; however, recurrence rates remain substantial, ranging from 20% to 45%. Previous studies have established a strong association between obstructive sleep apnea (OSA) and the risk of AF recurrence following ablation. While continuous positive airway pressure (CPAP) is the standard intervention for OSA, and some observational studies suggest it may reduce post-ablation recurrence in patients with comorbid OSA, small randomized controlled trials have failed to confirm a clear benefit, potentially due to poor adherence. This study aims to evaluate the clinical benefit of post-ablation CPAP therapy in AF patients with comorbid OSA. Participants will: * Be randomly assigned to either the CPAP group or the usual care group. * If in the CPAP group, use a CPAP device for 12 months. * Wear an ambulatory ECG recorder for a 7-day period at 3, 6, 9, and 12 months after randomization. * Complete follow-up checkups either at the clinic or over the phone at 1, 3, 6, and 12 months after randomization.

Conditions

  • Obstructive Sleep Apnea
  • Sleep Disorder (Disorder)
  • Atrial Fibrillation (AF)
  • Sleep Disordered Breathing (SDB)
  • Arrhythmia
  • Continuous Positive Airway Pressure

Interventions

  • Continuous Positive Airway Pressure (CPAP)Device

    Participants receive CPAP therapy provided by the research team. Treatment parameters are determined following auto-titrating or manual pressure titration. Prior to treatment initiation, participants receive training on device usage, mask fitting and adjustment, equipment cleaning and maintenance, and data transmission methods. Study physicians and technicians provide support to address any CPAP-related discomfort. 'Good adherence' is defined as device usage of ≥ 4 hours per night on ≥ 70% of days.

  • Usual CareOther

    Participants receive standardized medical therapy for atrial fibrillation in accordance with international guidelines and clinical routine. For OSA management, researchers provide standardized health education. This includes informing participants about the risks associated with OSA and advising on lifestyle modifications, including weight loss, adopting a lateral sleeping position, and avoiding alcohol and sedatives.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of freedom from atrial arrhythmia recurrence.Time frame: Within 12 months

Locations

30 sites in 1 country. Site status is shown where the registry gives one.

  • Tianjin Medical University Second Hospital

    Tianjin, China · Not yet recruiting

  • Beijing Chaoyang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Beijing Anzhen Hospital

    Beijing, Beijing Municipality, China · Recruiting

27 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.